HBsAg/HLA-A2 transgenic mice: A model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection

International Immunology

Volumn 15, Issue 10, 2003, Pages 1125-1136

  Loirat, D ^a,b   Mancini Bourgine, M ^a   Abastado, J P ^b   Michel, M L ^a  

^a INSTITUT PASTEUR   (France)

^b Immuno Designed Molecules   (France)

Author keywords

Inflammation; T lymphocyte; Vaccination; Viral infection

Indexed keywords

CD8 ANTIGEN; DNA VACCINE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ANTIVIRAL ACTIVITY; ARTICLE; CELLULAR IMMUNITY; CHIMERA; CHRONIC HEPATITIS; CONTROLLED STUDY; CYTOLYSIS; GENETIC CODE; HEPATITIS B; HEPATITIS B VIRUS; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; LIFESPAN; LIVER CELL; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERUM; T LYMPHOCYTE; TRANSGENE; TRANSGENIC MOUSE; VIRUS CARRIER; VIRUS EXCRETION;

ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; GENETIC VECTORS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HLA-A2 ANTIGEN; HUMANS; IMMUNE TOLERANCE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PLASMIDS; T-LYMPHOCYTES; TH1 CELLS; VACCINES, DNA; WHOLE-BODY IRRADIATION;

EID: 0141506102     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxg117     Document Type: Article

References (54)

1. h1 cells. Gastroenterology 116:1428.
2. + T cells results in antigen-specific T-cell tolerance. Nat. Med. 6:1348.
3. Sacher, T., Knolle, P., Nichterlein, T., Arnold, B., Hammerling, G. J. and Limmer, A. 2002. CpG-ODN-induced inflammation is sufficient to cause T-cell-mediated autoaggression against hepatocytes. Eur. J. Immunol. 32:3628.
4. + T cells by the normal liver. J. Immunol. 163:3202.
5. Shimizu, Y., Guidotti, L. G., Fowler, P. and Chisari, F. V. 1998. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J. Immunol. 161:4520.
6. Mancini, M., Hadchouel, M., Davis, H. L., Whalen, R. G., Tiollais, P. and Michel, M. L. 1996. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc. Natl Acad. Sci. USA 93:12496.
7. Chisari, F. V. and Ferrari, C. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29.
8. Ferrari, C., Penna, A., Bertoletti, A., Valli, A., Antoni, A. D., Giuberti, T., Cavalli, A., Petit, M. A. and Fiaccadori, F. 1990. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J. Immunol. 145:3442.
9. Jung, M. C., Spengler, U., Schraut, W., Hoffmann, R., Zachoval, R., Eisenburg, J., Eichenlaub, D., Riethmuller, G., Paumgartner, G., Ziegler-Heitbrock, H. W., et al. 1991. Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J. Hepatol. 13:310.
10. 2m double knockout mice. J. Exp. Med. 185:2043.
11. Babinet, C., Farza, H., Morello, D., Hadchouel, M. and Pourcel, C. 1985. Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice. Science 230:1160.
12. + T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses. Eur. J. Immunol. 29:1243.
13. Michel, M. L., Davis, H. L., Schleef, M., Mancini, M., Tiollais, P. and Whalen, R. G. 1995. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc. Natl Acad. Sci. USA 92:5307.
14. Davis, H. L., Whalen, R. G. and Demeneix, B. A. 1993. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4:151.
15. Mancini, M., Davis, H., Tiollais, P. and Michel, M. L. 1996. DNA-based immunization against the envelope proteins of the hepatitis B virus. J. Biotechnol. 44:47.
16. Davis, H. L., Weeratna, R., Waldschmidt, T. J., Tygrett, L., Schorr, J., Krieg, A. M. and Weeranta, R. 1998. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160:870.
17. Malanchere-Bres, E., Payette, P. J., Mancini, M., Tiollais, P., Davis, H. L. and Michel, M. L. 2001. CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice. J. Virol. 75:6482.
18. Loirat, D., Lemonnier, F. A. and Michel, M. L. 2000. Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization. J. Immunol. 165:4748.
19. Michel, M. L., Pontisso, P., Sobczak, E., Malpiece, Y., Streeck, R. E. and Tiollais, P. 1984. Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc. Natl Acad. Sci. USA 81:7708.
20. Farza, H., Salmon, A. M., Hadchouel, M., Moreau, J. L., Babinet, C., Tiollais, P. and Pourcel, C. 1987. Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice. Proc. Natl Acad. Sci. USA 84:1187.
21. Schweizer, J., Valenza-Schaerly, P., Goret, F. and Pourcel, C. 1998. Control of expression and methylation of a hepatitis B virus transgene by strain-specific modifiers. DNA Cell Biol. 17:427.
22. + T cell repertoire of HLA-A2.1 transgenic, H-2KbnullDbnull double knockout mice. J. Immunol. 163:2555.
23. Schirmbeck, R., Wild, J. and Reimann, J. 1998. Similar as well as distinct MHC class I-binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen. Eur. J. Immunol. 28:4149.
24. Rehermann, B., Ferrari, C., Pasquinelli, C. and Chisari, F. V. 1996. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat. Med. 2:1104.
25. Rehermann, B., Lau, D., Hoofnagle, J. H. and Chisari, F. V. 1996. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J. Clin. Invest. 97:1655.
26. Sette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J., Oseroff, C., Yuan, L., Ruppert, J., et al. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586.
27. Bertoletti, A., Chisari, F. V., Penna, A., Guilhot, S., Galati, L., Missale, G., Fowler, P., Schlicht, H. J., Vitiello, A., Chesnut, R. C., et al. 1993. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis 8 virus nucleocapsid protein. J. Virol. 67:2376.
28. Mancini, M., Hadchouel, M., Tiollais, P. and Michel, M. L. 1998. Regulation of hepatitis B virus mRNA expression in a hepatitis B surface antigen transgenic mouse model by IFN-gamma-secreting T cells after DNA-based immunization. J. Immunol. 161:5564.
29. McCluskie, M. J., Brazolot Millan, C. L., Gramzinski, R. A., Robinson, H. L., Santoro, J. C., Fuller, J. T., Widera, G., Haynes, J. R., Purcell, R. H. and Davis, H. L. 1999. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. Mol. Med. 5:287.
30. Firat, H., Garcia-Pons, F., Tourdot, S., Pascolo, S., Scardino, A., Garcia, Z., Michel, M. L., Jack, R. W., Jung, G., Kosmatopoulos, K., Mateo, L., Suhrbier, A., Lemonnier, F. A. and Langlade-Demoyen, P. 1999. H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies. Eur. J. Immunol. 29:3112.
31. Rehermann, B. 2000. Intrahepatic T cells in hepatitis B: viral control versus liver cell injury. J. Exp. Med. 191:1263.
32. Guidotti, L. G., Ishikawa, T., Hobbs, M. V., Matzke, B., Schreiber, R. and Chisari, F. V. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25.
33. Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R. and Chisari, F. V. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825.
34. Schultz, U., Kock, J., Schlicht, H. J. and Staeheli, P. 1995. Recombinant duck interferon: a new reagent for studying the mode of interferon action against hepatitis B virus. Virology 212:641.
35. Rollier, C., Sunyach, C., Barraud, L., Madani, N., Jamard, C., Trepo, C. and Cova, L. 1999. Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein. Gastroenterology 116:658.
36. Lu, M., Hilken, G., Kruppenbacher, J., Kemper, T., Schirmbeck, R., Reimann, J. and Roggendorf, M. 1999. Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection. J. Virol. 73:281.
37. Nayersina, R., Fowler, P., Guilhot, S., Missale, G., Cerny, A., Schlicht, H. J., Vitiello, A., Chesnut, R., Person, J. L., Redeker, A. G., et al. 1993. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol. 150:4659.
38. Webster, G. J., Reignat, S., Maini, M. K., Whalley, S. A., Ogg, G. S., King, A., Brown, D., Amlot, P. L., Williams, R., Vergani, D., Dusheiko, G. M. and Bertoletti, A. 2000. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32:1117.
39. Fu, T. M., Ulmer, J. B., Caulfield, M. J., Deck, R. R., Friedman, A., Wang, S., Liu, X., Donnelly, J. J. and Liu, M. A. 1997. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol. Med. 3:362.
40. Chattergoon, M. A., Robinson, T. M., Boyer, J. D. and Weiner, D. B. 1998. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. J. Immunol. 160:5707.
41. Stan, A. C., Casares, S., Brumeanu, T. D., Klinman, D. M. and Bona, C. A. 2001. CpG motifs of DNA vaccines induce the expression of chemokines and MHC class II molecules on myocytes. Eur. J. Immunol. 31:301.
42. Schirmbeck, R., Melber, K. and Reimann, J. 1995. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation. Eur. J. Immunol. 25:1063.
43. Sette, A. D., Oseroff, C., Sidney, J., Alexander, J., Chesnut, R. W., Kakimi, K., Guidotti, L. G. and Chisari, F. V. 2001. Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice. J. Immunol. 166:1389.
44. Kakimi, K., Isogawa, M., Chung, J., Sette, A. and Chisari, F. V. 2002. Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections. J. Virol. 76:8609.
45. Ando, K., Guidotti, L. G., Wirth, S., Ishikawa, T., Missale, G., Moriyama, T., Schreiber, R. D., Schlicht, H. J., Huang, S. N. and Chisari, F. V. 1994. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol. 152:3245.
46. Ando, D. G., Clayton, J., Kono, D., Urban, J. L. and Sercarz, E. E. 1989. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell. Immunol. 124:132.
47. Katz, J. D., Benoist, C. and Mathis, D. 1995. T helper cell subsets in insulin-dependent diabetes. Science 268:1185.
48. McIntyre, K. W., Shuster, D. J., Gillooly, K. M., Warrier, R. R., Connaughton, S. E., Hall, L. B., Arp, L. H., Gately, M. K. and Magram, J. 1996. Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice. Eur. J. Immunol. 26:2933.
49. Garza, K. M., Agersborg, S. S., Baker, E. and Tung, K. S. 2000. Persistence of physiological self antigen is required for the regulation of self tolerance. J. Immunol. 164:3982.
50. Limmer, A., Sacher, T., Alferink, J., Kretschmar, M., Schonrich, G., Nichterlein, T., Arnold, B. and Hammerling, G. J. 1998. Failure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironment. Eur. J. Immunol. 28:2395.
51. + T cells have a major 'post-licensing' role in CTL mediated anti-tumor immunity. J. Immunol. 165:6047.
52. Zajac, A. J., Blattman, J. N., Murall-Krishna, K., Sourdive, D. J., Suresh, M., Altman, J. D. and Ahmed, R. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205.
53. Reignat, S., Webster, G. J., Brown, D., Ogg, G. S., King, A., Seneviratne, S. L., Dusheiko, G., Williams, R., Maini, M. K. and Bertoletti, A. 2002. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J. Exp. Med. 195:1089.
54. Boni, C., Bertoletti, A., Penna, A., Cavalli, A., Pilli, M., Urbani, S., Scognamiglio, P., Boehme, R., Panebianco, R., Fiaccadori, F. and Ferrari, C. 1998. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J. Clin. Invest. 102:968.